PA
CVS icon

Paralel Advisors’s CVS Health CVS Stock Holding History

Paralel Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-39,485
Closed -$2.84M – 131
2026
Q1 		$2.84M Hold
39,485
– – 0.12% 53
2025
Q4 		$3.13M Hold
39,485
– – 0.12% 45
2025
Q3 		$2.98M Buy
39,485
+52
+0.1% +$3.56K 0.12% 49
2025
Q2 		$2.72M Buy
+39,433
New +$2.59M 0.11% 58

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Paralel Advisors's CVS Position: Q2 2026 in Review

Paralel Advisors sold out of CVS Health (CVS) in Q2 2026, closing a stake of 39,485 shares — an estimated $2.84M sold.

Paralel Advisors first reported a position in CVS in Q2 2025 and held it in 4 quarters. The position peaked at $3.13M in Q4 2025. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Paralel Advisors reported no remaining CVS Health position as of Q2 2026 after selling out during the quarter.
  • Paralel Advisors sold 39,485 CVS Health shares in Q2 2026, an estimated $2.84M.
  • Paralel Advisors first reported a position in CVS Health in Q2 2025 and held it in 4 quarters.
  • Paralel Advisors's CVS Health position peaked at $3.13M in Q4 2025.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Paralel Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.